NYSE · Healthcare · Healthcare Plans

Elevance Health, Inc. (ELV)

As of Nov 11, 4:00 PM ET, Elevance Health (ELV) last traded at $429.48, down 0.04% on the day. Its TickerHum research score is 56/100 (average). It reported revenue of $201.83B for the twelve months ending 2026-09-30, up 3.6% year over year, with a 2.7% operating margin.

Ratings

Reported fundamentals

MetricValuePeriod
Revenue$201.83BTTM ending 2026-09-30 · 10-Q
Revenue growth3.6%TTM ending 2026-09-30 · 10-Q
Net income$5.14BTTM ending 2026-09-30 · 10-Q
Diluted EPS$23.55TTM ending 2026-09-30 · 10-Q
Operating margin2.7%TTM ending 2026-09-30 · 10-Q
Net margin2.5%TTM ending 2026-09-30 · 10-Q
Free cash flow$6.51BTTM ending 2026-09-30 · 10-Q
Cash$10.35Bas of 2026-09-30 · 10-Q
Long-term debt$30.38Bas of 2026-09-30 · 10-Q
Debt / equity0.68as of 2026-09-30 · 10-Q

Source: SEC EDGAR XBRL company facts (CIK 0001156039).

Comparable companies for Elevance Health

Selected by industry, business overlap and scale; these are not necessarily direct competitors.

Prices: Yahoo Finance (public) — Free public Yahoo Finance data. Prices may be delayed and are for information only.